Drug Trial Radar · NCT07516093
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
620
Planned (sponsor's estimate)
Start
Aug 3, 2026
Primary completion
Oct 2029
Study completion Aug 2033
Sponsor
- Lead sponsor
- Nurix Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 7, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the efficacy and safety of NX-5948 (bexobrutideg) versus pirtobrutinib in participants with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who are relapsed or refractory to prior covalent Bruton tyrosine kinase inhibitor (cBTKi) treatment.
Conditions
- B-cell Lymphoma
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
Interventions
NX-5948Drug
Administered orally once daily
PirtobrutinibDrug
Administered orally once daily per prescribing information
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS) as assessed by Independent Review Committee (IRC)Time frame: Up to approximately 3.5 years
- Objective response rate (ORR) without partial response with lymphocytosis (PR-L) as assessed by IRCTime frame: Up to approximately 2.5 years
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Central Georgia Cancer Care
Macon, Georgia · Recruiting
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana · Recruiting
Hematology Oncology of Indiana
Indianapolis, Indiana · Recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
Texas Oncology - West Texas
Midland, Texas · Recruiting
Virginia Cancer Specialists
Fairfax, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.